The Premier Partnering & Investor Event of the Year

FEBRUARY 23 – 25, 2027 | THE LODGE AT TORREY PINES, LA JOLLA

Members-Only Discounts

Explore the registration discounts exclusively available to Biocom members, including our early bird rate.

Attendee Highlights

Explore the list of leading biotech and pharmaceutical companies, academic and research institutions, venture capital firms, and investment banks that have attended our exclusive conference.

Room & Lodging

With all conference activities taking place at The Lodge at Torrey Pines, there’s no better way to maximize your experience than staying on the property.

One-on-One Partnering

Learn more about using partneringONE®, including updating your profile, identifying potential partners and requesting meetings with fellow attendees.

About Our Conference

Our exclusive partnering and investor forum brings together over 500 investors and senior executives, including CEOs and heads of business development, licensing, M&A, and research and development from leading pharmaceutical, biotech and research organizations from across the globe. This prestigious conference features panel discussions, one-on-one partnering meetings, presentations from small companies and leading research institutions, and endless networking opportunities.

Featured Speakers

Meet the industry experts and thought leaders speaking at our conference.

Profile Headshot

Srini Akkaraju, M.D., Ph.D.

Founder & Managing Partner

Samsara BioCapital
Profile Headshot

Rachna Khosla

Senior Vice President, Business Development

Amgen
Profile Headshot

John Lepore, M.D.

CEO, ProFound Therapeutics; CEO-Partner

Flagship Pioneering
Profile Headshot

Mathai Mammen, M.D., Ph.D.

Chairman, CEO & President

Parabilis Medicines
Profile Headshot

Fiona H. Marshall, Ph.D.

President, Biomedical Research

Novartis
Profile Headshot

Sunil Patel

Head of Corporate Development and Business Development & Licensing

Merck
Profile Headshot

Andy Plump

President, Research & Development

Takeda Pharmaceutical Company Ltd.
Profile Headshot

Jeremy Quirk

VP BD&L Commercial Portfolio

GSK
Profile Headshot

Peter Schultz, Ph.D.

President, CEO & Professor of Chemistry

Scripps Research

stay-updated

Stay up to date on the latest information about #BiocomGPIC